| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/24/2004 | WO2003063802A3 Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer |
| 06/24/2004 | WO2003050238A9 Receptor-targeted adenoviral vectors |
| 06/24/2004 | WO2003049686A3 Stabilization of hypoxia inducible factor (hif) alpha |
| 06/24/2004 | WO2003047336A3 TRANSGENIC ANIMALS BEARING HUMAN Igμ LIGHT CHAIN GENES |
| 06/24/2004 | WO2003027264A3 Coisogenic eukaryotic cell collections |
| 06/24/2004 | WO2003008560A8 A novel g protein-coupled receptor, gave8 |
| 06/24/2004 | WO2002095055A3 Compositions and methods for use in isolation of nucleic acid molecules |
| 06/24/2004 | WO2002092758A9 Gastrokines and derived peptides including inhibitors |
| 06/24/2004 | WO2002086075A3 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
| 06/24/2004 | WO2001066563A8 T1r taste receptors and genes encoding same |
| 06/24/2004 | WO1999053016A3 Expression of alfin1 and methods for producing transgenic plants having increased root growth and root specific gene activation |
| 06/24/2004 | US20040122216 A mutein recombinant tissue protective cytokine lacking at least one activity selected from group consisting of increasing hematocrit, vasoactive action, hyperactivating platelets, pro-coagulant activities and increasing production of thrombocytes |
| 06/24/2004 | US20040121976 Anti-inflammatory vectors |
| 06/24/2004 | US20040121958 Methods of alleviating neuropathic pain |
| 06/24/2004 | US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals |
| 06/24/2004 | US20040121466 Alphavirus RNA replicon systems |
| 06/24/2004 | US20040121465 Optimization of gene sequences of virus-like particles for expression in insect cells |
| 06/24/2004 | US20040121464 Method for the preparation of cells of mesodermal lineage |
| 06/24/2004 | US20040121461 Bone marrow or cord blood cells transplanted into rat animal model comprised of demyelinated axons in order to remyelinate defective nervous system tissues; gene therapy and neurodegenerative disorders |
| 06/24/2004 | US20040121460 Pancreatic tissue culture prepared from embryonic stem cells for treatment of panreactic and diabetic disorders |
| 06/24/2004 | US20040121459 wherein few amounts of tissue blocks and cells are positioned within a porous multi-layer carrier consisting of a cavity structure which separates into different layers according to size; for use in bone transplants |
| 06/24/2004 | US20040121458 Culturable mitochondrial cells with no nucleus, showing mitochondrial activity |
| 06/24/2004 | US20040121457 Secondary sprouting for isolation and expansion of endothelial sprout cells and endothelial precursor cells from a mixed population and for screening substances |
| 06/24/2004 | US20040121430 Construct capable of release in closed circular form from a larger nucleotide sequence permitting site specific expression and /or developmentally regulated expression of selected genetic sequences |
| 06/24/2004 | US20040121411 for monitoring cleavage of beta-amyloid precursor protein (beta APP) by monitoring the fluorescent energy transfer between the adducts; for treating Alzheimer's disease |
| 06/24/2004 | US20040121397 Using prostate tissue messenger RNA to detect, diagnose, classify, monitor, prognosticate, prevent or treat cell proliferative disorders of urogenital system |
| 06/24/2004 | US20040121387 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/24/2004 | US20040121381 Identifying calcium channel modulators for treatment of autoimmune, inflammatory, allergenic, asthmatic and cell proliferative disorders |
| 06/24/2004 | US20040121376 Antisense modulation of interleukin-5 signal transduction |
| 06/24/2004 | US20040121372 Comprises receptors for advanced glycation endproduct polypeptides for use in diagnosis and treatment inflammation, infection, sepsis, autoimmune, atherosclerotic and nervous system disorders |
| 06/24/2004 | US20040121370 Novel composition and methods for the treatment of immune related diseases |
| 06/24/2004 | US20040121347 Isolation and expression of a gene for a nitrilase from Acidovorax facilis 72W |
| 06/24/2004 | US20040121345 Identification of a human n-terminal acetyltransferase gene |
| 06/24/2004 | US20040121325 Beta 1,2-xylosyltransferase-gene from arabidopsis |
| 06/24/2004 | US20040121303 includes cooling the sperm to a first temperature; maintaining the sperm sample at the first temperature; cooling the sperm to a second temperature; maintaining the sperm at the second temperature; and storing the sperm at a third temperature |
| 06/24/2004 | US20040121301 Agent imparting resistance to external stimuli |
| 06/24/2004 | US20040121300 includes a hydroxyethyl starch and/or derivative thereof alone or in combination with either dimethyl sulfoxide (DMSO) or glycerol; for recombinant live cancer cellular vaccine; kits |
| 06/24/2004 | US20040121022 Culture media and methods of making and using culture media |
| 06/24/2004 | US20040120955 D1-1 nucleic acids, polypeptides and related methods |
| 06/24/2004 | US20040120952 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 06/24/2004 | US20040120945 Cell surface molecule mediating cell adhesion and signal transmission |
| 06/24/2004 | US20040120935 Genetically modified yt cell line and use thereof |
| 06/24/2004 | US20040120934 Cloned ungulate embryos and animals, use of cells tissues and organs thereof for transplantation therapies including parkinson's disease |
| 06/24/2004 | US20040120933 Pax-encoding vector and use thereof |
| 06/24/2004 | US20040120932 Reprogramming a keratinocyte by treating with agent which promotes demethylation of a nucleic acid; and second agent to inhibit deacetylation of histone protein; reprogrammed cell expresses a telomerase gene |
| 06/24/2004 | US20040120929 Defective lentivirus pseudotyped with a lyssavirus envelope; selective transfer of genes into astrocytes of central nervous system; nervous system and brain disorders; viral diseases |
| 06/24/2004 | DE10257102A1 Preparing high purity cell types from stem cells, useful in drug screening and as transplantation material, by differentiation in an actively aerated bioreactor |
| 06/24/2004 | CA2547899A1 Cell-based therapies for ischemia |
| 06/24/2004 | CA2509058A1 Administration of dendritic cells partially matured in vitro for the treatment of tumors |
| 06/24/2004 | CA2508850A1 Engineering three-dimensional tissue structures using differentiating embryonic stem cells |
| 06/24/2004 | CA2508690A1 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 06/24/2004 | CA2507592A1 Magnetism based rapid cell separation |
| 06/24/2004 | CA2507581A1 Protection of stem cells from cytotoxic agents by modulation of .beta.-catenin signaling pathways |
| 06/23/2004 | EP1431394A1 Method to produce heterologous glycosylated proteins in bryophyte cells |
| 06/23/2004 | EP1431391A2 Rantes mutants and therapeutic applications thereof |
| 06/23/2004 | EP1431030A1 Thermo-formed cell culture vessel |
| 06/23/2004 | EP1430899A1 Graft from submucosal intestinal tissue for repairing neurological tissue |
| 06/23/2004 | EP1430152A2 Gene and protein relating to hepatocellular carcinoma |
| 06/23/2004 | EP1430137A2 Porcine adenovirus e1 and e4 regions |
| 06/23/2004 | EP1430133A2 A soluble toll-like receptor |
| 06/23/2004 | EP1430132A2 Methods of using 33751, a human potassium channel family member |
| 06/23/2004 | EP1430130A2 Nucleic acid-associated proteins |
| 06/23/2004 | EP1430129A2 Asip-related proteins |
| 06/23/2004 | EP1430126A1 Dna sequences for human angiogenesis genes |
| 06/23/2004 | EP1430125A2 Sperm-specific cation channel, and uses therefor |
| 06/23/2004 | EP1430124A2 Artificial ubiquitous chromatin opening elements (ucoe) |
| 06/23/2004 | EP1430118A2 A gene encoding cyclododecanone monooxygenase |
| 06/23/2004 | EP1430116A2 A packaging complementation cell-line for sv-40 vectors |
| 06/23/2004 | EP1430115A1 Immortilized stem cells |
| 06/23/2004 | EP1430114A2 Prolactin induced increase in neural stem cell numbers and therapeutical use thereof |
| 06/23/2004 | EP1430113A2 Effect of growth hormone and igf-1 on neural stem cells and therapeutic application |
| 06/23/2004 | EP1430111A1 Culture system for rapid expansion of human embryonic stem cells |
| 06/23/2004 | EP1430085A1 Leukocyte inactivation module |
| 06/23/2004 | EP1430083A2 T1r taste receptors and genes encoding same |
| 06/23/2004 | EP1430079A1 Fluorescent proteins |
| 06/23/2004 | EP1430078A2 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production |
| 06/23/2004 | EP1430076A2 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 06/23/2004 | EP1430067A2 Eukaryotic cells and method for preserving cells |
| 06/23/2004 | EP1429812A2 Unique properties of stem cells |
| 06/23/2004 | EP1429806A2 Extracellular massengers |
| 06/23/2004 | EP1429797A2 Diagnosis and treatment of malignant neoplasms |
| 06/23/2004 | EP1429648A2 METHODS FOR SCREENING FOR SUBSTANCES WHICH INHIBIT FP PROSTANOID RECEPTOR INTERACTION WITH A COMPOUND HAVING PGF 2$g(a)alpha?ACTIVITY AND METHODS OF TREATING CANCER |
| 06/23/2004 | EP1315410A4 Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase |
| 06/23/2004 | EP1282697A4 A construct capable of release in closed circular form from a larger nucleotide sequence permitting site specific expression and/or developmentally regulated expression of selected genetic sequences |
| 06/23/2004 | EP1265985A4 Pancreatic islet cell growth factors |
| 06/23/2004 | EP1263932A4 Embryonic stem cells and neural progenitor cells derived therefrom |
| 06/23/2004 | EP1171573B1 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 06/23/2004 | EP1131411B1 Suppression of xenotransplant rejection |
| 06/23/2004 | EP1068323B1 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 06/23/2004 | EP0871471B1 Compositions using morphogenic proteins and stimulatory factors |
| 06/23/2004 | EP0772676B2 Method of control of microorganism growth process |
| 06/23/2004 | EP0750505B1 Immunotherapy of cancer with allogeneic lymphocytes |
| 06/23/2004 | CN1507493A Biosynthetic genes for butenyl-spinosyn insecticide production |
| 06/23/2004 | CN1507488A Bio-reactor for tissue cultivated in the form of a thin layer and uses thereof |
| 06/23/2004 | CN1507452A Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 06/23/2004 | CN1506684A Prepn and application of human estrin receptor-resisting monoclonal antibody and human progestogen-resisting monoclonal antibody |
| 06/23/2004 | CN1506460A Method and kit for separating cell particle from sample |
| 06/23/2004 | CN1506457A Production process of mycosis-resisting rice variety |
| 06/23/2004 | CN1506456A External amplification process of gamma delta T-lymphocyte |
| 06/23/2004 | CN1154743C Amphotropic retrovirus packaging cell line, process for its production and use thereof |